The present and future of home care chemotherapy for patients with advanced and recurrent colorectal cancer
Takahashi, K.; Mori, T.; Yamaguchi, T.; Matsumoto, H.; Miyamoto, H.; Arai, K.; Iwasaki, Y.; Katayanagi, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(Suppl 2): 154-156
2004
ISSN/ISBN: 0385-0684 PMID: 15645757 Document Number: 584079
If the chemotherapy at home is as effective as the chemotherapy at an outpatient clinic, QOL of the patients will be improved. In this paper the future of chemotherapy at home was clarified from the outcome of the chemotherapy for advanced and recurrent colorectal cancer. Hepatic arterial infusion chemotherapy (HAI) (5-FU 2,000 mg/w, continuous infusion for 7 days, n=123) for unresectable liver metastases and FL chemotherapy (5 FU 1,500 mg + l-LV 375 mg/w, continuous systemic chemotherapy for 7 days, n=32) for extra hepatic recurrence were carried out at home by a portable pump system every other week. The response rates were 61.2% in HAI and 18.8% in FL. MST were 14.7 months in HAI and 10.8 months in FL. It was important to establish a surveillance network system to continue the chemotherapy at home. It was suggested that the chemotherapy at home was effective and to maintain the patient's QOL as one of the options.